FOLLOW US

Industry News November 15, 2024 6 mins read

The Company that is Making Marijuana Great Again – Kalytera

Industry News ı By Jeff Watterson

0 Comments

clinic-doctor-health-hospital

Medical Marijuana is currently legal in 28 states, as well as Washington D.C. 2016 was a great year for the medical marijuana industry, with Arkansas, Florida, North Dakota, Ohio, and Pennsylvania implementing legislation and ballot initiatives to legalize medical use.  Along with these initiatives, industry leaders have taken steps to solidify their spot in the market, demonstrate earning potential, and debunk associated stigmas.

Political action aside, widespread use and adoption of any medical treatment requires vetting, and vetting relies on research.  Increased research into cannabidiol (CBD) is expected to strengthen the industry.  The Drug Enforcement Administration, the primary agency for federal enforcement of marijuana laws, has recently increased the number of authorized manufacturers that supply their research.  According to the agency, “This change illustrates the DEA’s commitment to working with the FDA and NIDA to facilitate research concerning marijuana and its components.”

Medical marijuana has seen a lot of interesting research over the last decade. It has been observed to have efficacy in relieving pain, anxiety, symptoms of Multiple Sclerosis, Glaucoma, and a wide variety of other medical conditions. Many of these symptoms are treated specifically using cannabidiol (CBD), a substance found in marijuana. CBD does not have the psychoactive qualities that many associate with recreational marijuana use.

“CBD has shown for some time now (decades) that it can have a medicinal effect.” Says CNN’s Dr. Sanjay Gupta. Gupta, a former critic of medical marijuana, has written articles and produced documentaries extolling the benefits of the controversial drug. According to Gupta, medical marijuana research “is about emerging science that not only shows and proves what marijuana can do for the body but provides better insights into the mechanisms of marijuana in the brain, helping us better understand a plant whose benefits have been documented for thousands of years.”

According to Dr. Raphael Mechoulam, Ph.D., “Cannabis has been used as a medicinal agent for thousands of years. We have evidence that the Assyrians used it in what seem to be neurological diseases, the Greeks and the Romans used it for inflammation.”

Mechoulam is the Co-Chair of the Scientific Advisory Board for Kalytera, a company that is working to develop proprietary drugs that use CBD. “Kalytera was established in order to evaluate and develop cannabinoid drugs…compounds based on the plant material…we’re studying the cannabinoid system and then preparing new compounds based on the cannabinoid system both in the plant and in the body to get better compounds, better drugs.”

Unfortunately, according to Kalytera, a company that is developing proprietary drugs that use CBD, “there are limitations associated with natural CBD, including its poor oral bioavailability and short half-life.”

Bioavailability is the portion of a drug or substance that can be absorbed and affect the body. Different methods of ingestion will affect the bioavailability. For example, when inhaled CBD has a bioavailability of 31%. In contrast, when it is taken orally, its bioavailability is only 6%.

Kalytera is working to create a new class of CBD drugs with increased bioavailability to deliver more effective doses to patients. They are doing this through research on two fronts.

 

The first front focuses on further research into the use of CBD. Combining what is already an impressive body of research on the substance with a more in-depth clinical analysis, Kalytera hopes “to expedite regulatory approval and commercialization.” Their CBD research includes several programs that study the efficacy of CBD in bone health and healing for patients with Osteoporosis, bone fractures, Osteogenesis imperfecta, and Prader-Willi Syndrome (PWS).

The second front involves developing and creating synthetic cannabinoids with better bioavailability to deliver more efficient doses.

Kalytera’s research programs study the use of CBD in conjunction with these synthetic cannabinoids in treating patients.

In the 1960’s, Dr. Raphael Mechoulam, an Israeli researcher, was one of the first to successfully identify THC and CBD, the main components of marijuana. His research led him to petition the Israeli Ministry of Health to approve medical marijuana in 1992 and establish a program for researchers and patients, a move which has positioned Israel at the forefront of medical marijuana research.

Kalytera, in efforts to further this research, has partnered with the Hebrew University of Jerusalem and exclusively licensed synthetic cannabinoids KAL 436/9 and 671.

Kalytera researchers have studied the ability of KAL436/9 to improve bone fracture healing and strengthen bones in patients suffering Osteogenesis imperfecta (brittle bone disease).

Researchers are exploring KAL671 for preventing bone loss in mice with PWS.  Thus far, it’s demonstrated the ability to restore bone growth and inhibit bone resorption.  It is also non-toxic in preclinical animal models.

On the 13th of January 2016, Kalytera announced that they have entered a binding letter of intent to acquire securities of Talent Biotechs Ltd., a private Israel-based developer of CBD therapeutics. Under this agreement, they have made a non-refundable payment of $1,000,000. This acquisition will allow Kalytera to further tap into the wealth of Israeli research on medical marijuana.

Talent is performing pioneering studies on the treatment of graft versus host disease (GvHD) - a potential complication in bone marrow transplant patients - and they have gained four orphan drug designations in the US and Europe. In May of 2015, Chief Medical Officer of Talent, Moshe Yeshurun, M.D., published a study demonstrating CBD’s efficacy in dealing with complications resulting from bone marrow transplants.

According to David Stefansky, Co-Founder of Kalytera and Chairman of the Board of Directors, “We are thrilled to announce the signing of this LOI, which brings us closer to acquiring a late-stage program in GvHD with strong proof-of-concept.  There are currently few options to prevent or treat GvHD. We feel incredibly fortunate to be working towards the advancement of this important program.”

Andrew Salzman, M.D., Kalytera Chief Executive Officer added, “Multiple studies have demonstrated that CBD possesses remarkable therapeutic potential across a broad range of diseases and disorders.  The proposed acquisition of Talent and its late-stage GvHD program significantly advances Kalytera’s mission of becoming a global leader in CBD pharmaceuticals. We are encouraged by Talent’s GvHD data, and we are hopeful that Kalytera will be able to rapidly advance the program into placebo-controlled, double-blind, randomized studies.”

Beyond their ground-breaking research, Kalytera has all the pieces in place to become a leader in the medical marijuana industry. They have assembled a leadership team composed of some of the greatest minds in medical research and development, including: David Stefansky, Co-Founder and Chairman, Andrew L. Salzman, MD., Chief Executive Officer and Chief Medical Officer, Raphael Mechoulam, Ph.D., Robert Farrell, President, COO and CFO, and Seth Yakatan, Co-founder and Director.

Kalytera announced on January 11th, 2017, that its common shares commenced trading on the TSX Venture Exchange. The shares are trading under “KALY.”

 

Previous Article

Applications Opening Soon – Pennsylvania’s Up and Coming Marijuana Industry

Read More
100 Posts

Jeff Watterson

Jeff Watterson is a journalist that focuses on politics, investigative journalism, and technology news. When Jeff is not writing, which is his hobby, he enjoys fishing and hunting.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 20, 2026 Anthropic Stock Slides After Record-Breaking IPO By – Jackie Allen
Breaking News November 20, 2026
Seven Straight Days of Red: The…

Chip stocks crashed in Asia, Europe sold off and Anthropic…

By – Derek Johnson
America November 20, 2026
How One Hat Killed America’s Favorite…

Fiona, the Cincinnati Zoo hippo born six weeks premature in…

By – Derek Johnson
America November 19, 2026
Technology Disruption Hits Major Banks, Microsoft…

NEW YORK — A wave of technology disruption has affected…

By – Jackie Allen
America November 19, 2026
No CyberAttack: FAA Lifts Nationwide Ground…

The Federal Aviation Administration (FAA) has lifted a nationwide ground…

By – Jackie Allen
USA Herald November 19, 2026
Rosa Leyva Murder: Oregon Man Believed…

OREGON CITY, Ore. — Rosa Leyva, 61, was fatally shot…

By – Jackie Allen
America November 19, 2026
Dallas Police Department Faces Federal Lawsuit…

 The Dallas Police Department is facing renewed scrutiny following a…

By – Jackie Allen
America November 19, 2026
New Hampshire Auto, Home Insurance Reductions:…

In a year when many bills only move one direction,…

By – Tyler Brooks
America November 19, 2026
GTA VI launch spotlights systemic cyber…

The GTA VI insurance risks are not about the game…

By – Tyler Brooks
America November 19, 2026
Walmart raises its outlook for the…

Walmart raises outlook for the third time this year, but…

By – Rachel Moore
America November 19, 2026
Bed bugs force FEMA staff to…

The FEMA bed bugs story adds an unlikely twist to…

By – Rachel Moore
America November 19, 2026
Anthropic shares jump 21% after $107.3B…

The Anthropic $107.3B IPO opened with a bang on Thursday.…

By – Rachel Moore
America November 19, 2026
Binance Wins $6.5B Freezing Order Over…

The Binance $6.5B freezing order may be the biggest legal…

By – Rachel Moore
America November 19, 2026
Polaris $1M Data Privacy Settlements: California…

The Polaris $1M data privacy settlements show what happens when…

By – Rachel Moore
America November 19, 2026
 Anti-Death-Penalty Groups Intensify Fight Against Capital…

  The United States recorded 37 executions in 2026 as…

By – Jackie Allen
America November 19, 2026
43 Soldiers Unlock a GTA 6…

FORT STEWART, Ga. — The 9th Brigade Engineer Battalion offered…

By – Michallie K Harrison
America November 19, 2026
Palmer Luckey Warns AI Hackers Are…

NEW YORK — Palmer Luckey says artificial intelligence is giving…

By – Michallie K Harrison
America November 19, 2026
Iowa Schools Cancel Classes as Army…

MIDDLETOWN, Iowa — Schools in southeast Iowa have canceled Friday…

By – Michallie K Harrison
America November 18, 2026
Government Investigators Find AI Platforms Generated…

Federal investigators found that four major artificial intelligence platforms could…

By – Jackie Allen
Breaking News November 19, 2026
Anthropic Hits the Nasdaq Today as…

Anthropic begins trading as “ANT” on the Nasdaq after selling…

By – Derek Johnson
America November 18, 2026
Yellowstone’ Star Luke Grimes Opens Up…

Key Takeaways Luke Grimes admits he was worried about continuing…

By – Jackie Allen
America November 18, 2026
Florida Flood Threat: Record Downpours Swamp…

The Florida flood threat turned real overnight. Torrential rainfall and…

By – Tyler Brooks
America November 18, 2026
Is GTA 6 Out? Rockstar’s Blockbuster…

Is GTA 6 out? The answer depends on where you…

By – Tyler Brooks
Business November 18, 2026
GTA VI Is Finally Here: Rockstar’s…

Grand Theft Auto VI began rolling out at midnight in…

By – Derek Johnson
America November 18, 2026
Iran Says It Targeted Kuwaiti Air…

Iran’s military said it targeted Ali Al Salem Air Base…

By – Michallie K Harrison
America November 18, 2026
13 U.S. Babies Born With Measles…

U.S. officials documented 13 babies born with measles and 112…

By – Michallie K Harrison
America November 17, 2026
Katie Couric Reveals  Memory-Loss Episode That…

Katie Couric is opening up about a recent frightening medical…

By – Jackie Allen
America November 15, 2026
Hackers Hit America’s Drinking Water Systems…

ATLANTA – Hackers have crossed a dangerous line in America’s…

By – Samuel Lopez
America November 15, 2026
America Loses Its Measles-Free Status for…

PAHO says the U.S. no longer meets the standard for…

By – Derek Johnson
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 17, 2026
Content Creator Chrisean Rock Faces Looming…

By Samuel Lopez – USA Herald INGLEWOOD, Calif. – What…

By – Samuel Lopez
America November 15, 2026
Tower Hill Investment in Gator Athletics:…

The Tower Hill investment in Gator Athletics just rewrote the…

By – Tyler Brooks
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter